ClinicalTrials.gov
ClinicalTrials.gov Menu

Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00328367
Recruitment Status : Completed
First Posted : May 19, 2006
Last Update Posted : October 29, 2008
Sponsor:
Collaborator:
Korea Otsuka Pharmaceutical Co., Ltd.
Information provided by:
Seoul National University Hospital